Drug intelligence / Profile preview

Suclear

Development stage
Unknown
Lead developer
Braintree
Modality
Small Molecules
Administration
Oral
01

Overview

Suclear is an osmotic laxative kit developed by Braintree Laboratories (a subsidiary of Sebela Pharmaceuticals) for bowel cleansing in preparation for colonoscopy in adults. The product is supplied as a co-packaged kit containing two components: a 6-ounce bottle of oral solution consisting of sodium sulfate, potassium sulfate, and magnesium sulfate, and a 2-liter jug containing powder for oral solution consisting of polyethylene glycol 3350 (PEG-3350), sodium chloride, sodium bicarbonate, and potassium chloride. The mechanism of action is primarily physical; the sulfate salts and PEG-3350 are poorly absorbed and exert an osmotic effect, retaining water within the intestinal lumen. This results in a copious watery diarrhea that effectively cleanses the colon to allow for clear visualization during endoscopic procedures.

Brand names
Suclear
Other names
sodium sulfate, potassium sulfate, and magnesium sulfate oral solution; and PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solutionPEG-3350 with electrolytes and sulfate saltsPEG3350 with electrolytes and sulfate saltsPEG 3350 with electrolytes and sulfate salts

Beyond the preview

Go deeper on Suclear.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suclear.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call